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ABSTRACT

Cytolethal distending toxin (CDT) is a virulence factor produced by many Gram-negative bacteria,
including Haemophilus ducreyi. This fastidious pathogen is the causative agent of genital cancroid.
CDT is a heterotrimeric toxin with an AB2 structure consisting of a cell-binding “B” domain (CdtA
+ CdtC) and a catalytic “A” domain (CdtB) that has DNase activity. This toxin assembles in the
bacterial periplasm that lacks ATP and is secreted into the extracellular environment. After cell
binding, CDT is internalized by endocytosis and travels through the endosomes and Golgi before
arriving in the endoplasmic reticulum (ER). CdtA is lost from the holotoxin before reaching the
Golgi, and CdtB separates from CdtC in the ER. CdtB is then transported into the nucleus, inducing
cell cycle arrest and apoptosis. Using disassembly of the AB 5 pertussis toxin as a model, we
explore that ATP, which is present in the ER lumen but not in the endosomes or Golgi, will cause
dissociation of the CdtB/CdtC heterodimer. We have cloned and purified the three individual
subunits of the H. ducreyi CDT. When combined, the subunits form a lethal holotoxin. Examining
the individual toxin subunits, only CdtB binds with ATP but does not function as an ATPase.
CdtB’s binding to ATP also does not cause global changes to its secondary structure. After
isolating the CdtB/CdtC heterodimer, we have shown the addition of ATP causes CdtC to
dissociate from CdtB. The work presented in this Thesis provides a molecular basis for why the
CdtB/CdtC heterodimer disassembles after reaching the ER and confirms the novel two-stage
disassembly mechanism for CDT, a first in the AB toxin field.
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CHAPTER 1: INTRODUCTION AND BACKGROUND
Cytolethal distending toxin (CDT) is a virulence factor produced by many Gram-negative
pathogens including Haemophilus ducreyi, Escherichia coli, Campylobacter jejuni, and
Aggregatibacter actinomycetemcomitans [1]. This thesis focuses on the CDT produced by H.
ducreyi, a fastidious Gram-negative coccobacillus linked to a sexual transmitted infection (STI)
prevalent in Africa known as genital chancroid [2-4]. CDT contributes to the infectious process by
inducing apoptosis in lymphocytes, thus allowing bacterial persistence at the site of infection by
inhibiting an adaptive immune response [5, 6].

Structure
CDT is part of the AB toxin family, which includes a large group of bacterial toxins that share a
common structural organization comprised of a catalytic A subunit and a cell binding B subunit.
CDT is a heterotrimeric AB2 genotoxin with one catalytic protein (CdtB) and two cell-binding
proteins (CdtA and CdtC) (Fig. 1). It is encoded by the cdt operon contained in the bacterial
genome, with cdtB located between cdtA and cdtC [7]. The genes in an operon are labeled
alphabetically in the order they are transcribed, explaining why the catalytic A protein is identified
as the CdtB subunit. After translation, the holotoxin spontaneously assembles in the neutral pH
environment of the bacterial periplasm and is secreted into the extracellular space. Unlike most
other AB toxins, CDT does not have disulfide linkages to maintain holotoxin structure [7].
Noncovalent protein-protein interactions are sufficient to assemble and maintain a stable CDT
holotoxin [7].
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Figure 1: Ribbon diagram of CDT holotoxin.
CDT is a heterotrimeric AB2 toxin. CdtA (blue) and CdtC (red) make up the cell binding “B”
domain. CdtB (green) is the catalytic “A” domain. The N-terminal region of CdtC is seen blocking
the active site of the DNase I domain in CdtB, requiring toxin disassembly to activate the latent
DNase activity of CdtB. PDB 1SR4 [7, 8]

2

Function
CdtA and CdtC make up the cell binding “B” domain that binds to lipid rafts, specific regions with
high cholesterol in the plasma membrane [9, 10]. Both subunits also contain lectin motifs that are
similar to the cell-binding subunit of ricin, another AB toxin [11]. Lectin motifs recognize specific
glycan modifications present on proteins and lipids, but the exact configuration of sugar residues
on CDT surface receptors has not yet been identified for HdCDT [12]. Lipid rafts are required for
intoxication while the lectin binding interactions only play an accessory role [9, 10, 12].

CdtB is the catalytic A subunit that contains structural similarities to the DNase I endonuclease
family [7]. Like DNase I, CdtB can cause double-stranded DNA breaks [13, 14]. This triggers a
DNA repair response mediated by ataxia-telangiectasia mutated (ATM), a kinase that
phosphorylates the H2AX histone. This modification recruits the MRN complex to repair DNA
either by homologous recombination or non-homologous end joining repair [10, 15]. During this
process, the cell cycle will be arrested during G1 or G2 phase [16]. Cellular expansion is still active
during this arrest, leading to a distended phenotype. If DNA repair is successful, the cell will
resume through the cell cycle. Failure will induce apoptosis.

Trafficking
In order for CdtB to reach the DNA, it must travel from the extracellular space to the nucleus [6,
17]. This pathway involves several steps, including (i) CDT holotoxin binding to the host plasma
membrane binding; (ii) internalization in a clathrin- and dynamin-dependent manner; (iii) vesicle
transport passing through the early and late endosomes before reaching the Golgi apparatus; and
(iv) retrograde transport from the Golgi apparatus to the endoplasmic reticulum (ER). After
3

reaching the ER, only CdtB is transported into the nucleus where it causes double-stranded breaks
in the host DNA [10, 13, 18-21].

Two-Stage Disassembly
Although all three Cdt subunits are required for cellular intoxication, CdtC blocks CdtB active site,
so disassembly is required to cause DNA damage after reaching the nucleus [18, 22, 23]. Confocal
microscopy did not detect an intracellular pool of CdtA, which suggested CdtA is left on the cell
surface while the CdtB/CdtC heterodimer is internalized [24]. However, this negative result does
not eliminate the possibility of CdtA internalization and/or recycling. For example, CdtA could
dissociate from CdtB/CdtC in the endosomes after holotoxin internalization and then return to the
surface. Only CdtB and CdtC arrive at the Golgi apparatus after passing through the endosomes,
as demonstrated by the sulfation of recombinant CdtB and CdtC but not CdtA [10, 25, 26].
Sulfation is a protein modification specific to the Golgi apparatus, so the lack of CdtA sulfation
indicates that CdtA disassociated from the CdtB/CdtC heterodimer before their arrival to the Golgi
[25, 26]. Whether CdtA dissociation from CdtB/CdtC occurs at the cell surface or in the
endosomes, there is a consensus that CdtA is lost early in the transport pathway. This is the first
stage of CDT disassembly. CdtB and CdtC are further transported to the ER demonstrated by
confocal microscopy [24]. However, only CdtB delivery to the ER was confirmed by Nglycosylation, the attachment of glycans to asparagine amino acids that occurs in the ER. Nglycosylation was not tested with CdtC. [10, 27]. Since CdtB alone is transported to the nucleus,
the intracellular transport of CDT involves a novel two-stage disassembly process as summarized
in Figure 2.
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Figure 2: Intracellular transport and disassembly of CDT.
CDT undergoes retrograde transport passing through the endosomes and Golgi apparatus before
arriving in the ER. CdtA dissociates from the CdtB/CdtC heterodimer before reaching the Golgi
apparatus [25]. Only CdtB moves from the ER lumen into the nucleus. Adapted from [28].
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CHAPTER 2: THESIS AIM AND RATIONALE
Thesis aim: Elucidate the molecular mechanism for CdtB/CdtC disassembly.
There are many CDT studies detailing its possible binding receptors, intracellular trafficking route,
and cellular response mechanisms after intoxication. Yet the molecular mechanism by which CDT
disassembles before ER translocation has not been addressed. After the crystal structure of HdCDT
was solved in 2004, computer modeling showed that the N-terminal tail of CdtC is blocking the
DNA binding site of CdtB. Thus, CdtB must separate from CdtC for DNase activity [7, 29]. The
goal of this thesis is to detail the mechanism of how CdtB and CdtC dissociate while in the
heterodimer conformation during intracellular transport.

Most AB toxins contain a disulfide bond that is necessary to maintain their structure and requires
chaperone intervention for disassembly [30-32]. Pertussis toxin (PT), similar to CDT, is an ERtranslocating AB toxin held together by noncovalent protein-protein interactions rather than a
disulfide bond (Fig. 3) [33]. After transport into the ER, the catalytic S1 subunit of PT (PTS1) is
released from its B pentamer (PTB) in an ATP-induced, chaperone-independent manner [34-36].
Disassembly results from ATP entering into the pore of the ring-like PTB pentamer, causing a
conformational change that weakens the association between PTS1 and the PTB pentamer [35].
Using the disassembly of PT as a model, we hypothesize that ATP will induce the disassembly of
the CdtB/CdtC heterodimer. ATP is not present in the bacterial periplasm, endosomes, or Golgi
apparatus, but it is present in the ER [26, 37, 38]. ATP could thus act as a molecular sensor to
activate CdtB/CdtC disassembly at the CdtB translocation site [37].
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Previously, it has been shown by surface plasmon resonance (SPR) [39, 40] that CdtC will
dissociate from the CdtB in the presence of ATP (Fig. 4). After CdtB was appended to the SPR
slide, CdtC was injected into the profusion buffer and formed a stable complex with CdtB.
Disassembly did not occur after a drop in pH, a characteristic in the endosomes [38]. Instead,
disassembly occurred after the addition of ATP. The loss of CdtC and retention of CdtB was
verified by the addition of subunit-specific polyclonal antibodies (Fig. 4). The CdtB/CdtC
heterodimer will not encounter ATP until it reaches the ER. Thus, after delivering CdtB to the ER,
CdtC will be released after which CdtB is then transported into the nucleus. Further
characterization of this mechanism is presented here; this work provides a molecular basis for a
key, but poorly understood event during CDT intoxication.
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Figure 3: The ribbon diagram of pertussis toxin.

Pertussis toxin is an AB5 toxin comprised of PTB and PTS1. The pentameric cell-binding B
domain (blue) is made up of five proteins: S2, S3, S4 (two copies), and S5. PTS1 is the A
catalytic domain (red). PDB 1PRT [33]
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Figure 4: ATP disassembly of the CdtB/CdtC heterodimer detailed by SPR.
At 0 sec, CdtC was perfused over an SPR slide previously bound with CdtB. The buffer was
changed to pH 5.2 at 180 sec (asterisk). At 350 sec, the pH was raised to 7.4 and 200 µM ATP was
added to the buffer (plus sign). Anti-CdtC, then anti-CdtB antibodies were added at the indicated
times. CdtC dissociated from CdtB with the addition of ATP, while CdtB remained bound to the
SPR slide. This experiment was performed by Dr. Mike Taylor and John Clore.
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Significance and implication
The CDT produced by H. ducreyi has been shown to induce apoptosis in B-lymphocytes, Tlymphocytes, and immature dendritic cells - all key cells in the adaptive immune response [5, 41,
42]. Currently, there are no studies focused on CDT’s disassembly. Host-toxin interactions
involving CDT have mainly focused on identifying the cell-binding event, intracellular transport
route, or cellular response mechanisms. CDT is the first AB toxin that has two stages of
disassembly, but the mechanism and rationale for this two-stage event are unknown.
Understanding this disassembly mechanism can provide additional information that could
establish alternative treatment methods for CDT-producing bacterial infections. Preventing
disassembly of CDT may prevent CdtB from generating DNA damage. This, in turn, could inhibit
the effect seen in adaptive immune cells that restricts the humoral response and could thereby
provide an alternative to antibiotic treatments.
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CHAPTER 3: MATERIALS AND METHODS
CDT toxin subunits


Dr. Tersea Frisan (Karolinska Institutet; Stockholm, Sweden) generously gifted cdtA, cdtB,
and cdtC coding sequences that were inserted into the bacterial expression vector pGEX3T3.



Insertion of the cdt coding sequences into the pET-28(a) bacterial expression vector was
previously done by Dr. Lucia Cilenti.

Additional cloning of Cdt subunits
Glycerol stocks of Escherichia coli strain DH5α carrying pET-28(a) plasmids encoding for CdtA,
CdtB, or CdtC were streaked onto sterile lysogeny broth (LB) agar plates containing 50 µg/mL of
kanamycin and 0.02% glucose [43]. Individual colonies were selected and inoculated in 5 mL of
sterile LB containing 50 µg/mL kanamycin and 0.02% glucose. Plasmid DNA was harvested using
Macherey-Nagel’s (Bethlehem, PA) Nucleospin Plasmid kit. Using ‘Round-the-horn [44] sitedirected mutagenesis, plasmids were amplified using the Thermo Scientific™ (Waltham, MA)
Phusion Site-Directed Mutagenesis Kit. The primers used are detailed in Table 1. After ligation,
DNA was transformed into DH5α cells using a one-step transformation method [45]. After
recovery for 1 h at 37°C with shaking in 1 mL of LB, the cells were pelleted at 5000 × g for 5 min,
resuspended in 100 µL of LB, and plated onto LB agar plates containing 50 µg/mL of kanamycin
and 0.02% glucose. Multiple colonies were selected and grown individually overnight in 6 mL of
LB containing 50 µg/mL of kanamycin and 0.02% glucose. Glycerol stocks of DH5α cells were
generated by combining 900 µL of the individual cultures with 900 µL of PBS (pH 7.4) containing
50% glycerol and stored at -80°C. Plasmid DNA was harvested from the remaining inoculum and
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sent for sequencing. After verification of the deletion, the plasmid DNA was transformed into E.
coli strain BL21(DE3)pLysS using the transformation method above and plated on LB agar plates
containing only 50 µg/mL of kanamycin. Glycerol stocks for the individual subunits were
generated as described above and kept at -80°C. The addition of glucose with DH5α cells was to
increase bacterial growth, in turn increasing potential DNA recovery yield of the low-copy pET28(a) plasmid. For BL21(DE3)pLysS growth, glucose was absent in order to prevent bacterial
stress incurred by the diauxic transition to LB media metabolism that would inhibit protein
production.
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Table 1: Primers used for subcloning cdt sequences

Primer Name

Primer sequence 5´ – 3´

CdtA forward

ATGCATCATCATCATCATCACTGTTCATCAAATCAACGAATGAATGAC

CdtB forward

ATGCATCATCATCATCATCACAACTTGAGTGACTTCAAAGTAGCAAC

CdtC forward

ATGCATCATCATCATCATCACAGTCATGCAGAATCAAATCCTGATCCG

pET-28(a) reverse

GGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTCTAGAGGGGAATTGTTATCCGC

List of DNA primers used for ‘Round-the-horn site-directed mutagenesis of cdt coding sequences. All sequences were contained in
the pET-28(a) bacterial expression vector with a N-terminal hexahistidine sequence. Each plasmid contained a linker region between
the N-terminal hexahistidine tag and subunit coding sequence. The forward primers were used to amplify the subunit coding
sequence with the incorporation of a hexahistidine tag, while the reverse was used to amplify the vector. The pET-28(a) reverse
primer served as the reverse primer for each reaction.
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Protein purification
E. coli strain BL21(DE3)pLysS carrying a pET-28(a) plasmid containing the correct subunit
sequence was streaked onto LB agar plates containing 50 µg/mL of kanamycin from glycerol
stocks. An individual colony was incubated overnight in 5 mL of LB containing 50 µg/mL
kanamycin, then expanded into 1 L of LB at the same antibiotic concentration. After reaching an
O.D.600 between 0.4 to 0.6, the culture was induced with 1 mL of 1 M IPTG and incubated for an
additional 4 to 6 h. Induced cultures were then pelleted by centrifugation, spinning at 6,000 × g
for 20 min. Pellets were resuspended in 20 mM Tris (pH 7.5) with 25 mM NaCl and pelleted again
to remove any remaining LB media. Pellets were stored at -80°C until protein extraction.

Bacterial cells were lysed using B-PER II (ThermoScientific; Waltham, MA) containing 100
µg/mL lysozyme (reconstituted in 1 mL of 20 mM Tris pH 7.4 with 150 mM NaCl), shaking at
150 rpm for 20 min at 37°C, followed by centrifugation at 12,000 × g for 30 min. Since neither of
the subunits are solubly expressed in viable quantities, the supernatant was discarded, and the
insoluble pellet was solubilized with rocking at 4°C for 2 h in 50 mM Tris (pH 8.0) containing 300
mM NaCl and 8 M urea. The now-soluble protein solution was added to a 2 mL bed volume
TALON Cobalt Metal Affinity Resin (Takara Bio; Mountain View, CA) for 2 h, allowing for
efficient His-tag binding. The slurry was spun down at 500 × g for 5 min. The supernatant was
collected and labeled as “Did Not Bind”. The TALON beads were then resuspended in 15 mL of
50 mM Tris (pH 7.0) with 600 mM NaCl and 8 M urea, gently rocked for 15 min and transferred
into a gravity column. The flow through was collected and labeled as “Wash 1”. The TALON
beads were further washed with three column volumes of 50 mM Tris (pH 7.0) with 300 mM
14

NaCl, 8 M urea, and 10 mM imidazole. The collected flow-through was labeled as “Wash 2”.
Proteins were then eluted in an increasing imidazole gradient, starting at 20 mM and finishing at
300 mM, in 20 mM Tris (pH 7.0). Fractions were visualized via 15% Tris-glycine SDS-PAGE gel
and Coomassie stain. Fractions selected based on purity were then dialyzed against 20 mM HEPES
buffer (pH 7.4), with decreasing urea concentrations starting at 6 M and transitioning in a stepwise
fashion from 6 M for 2 h, 4 M overnight, 2 M for 2 h, down to 0 M, repeating the 0 M step 3 times
at 1 h each, all at 4°C. Protein concentrations were calculated by BCA assay (Thermoscientific;
Waltham, MA) according to manufacturer’s instructions. All subunits were stored at 4°C for
further use.

Western blot visualization
All samples were first resolved using a 15% Tris-glycine SDS-PAGE gel. After electrophoresis,
the stacking portion of the gel was removed and the resolving portion was equilibrated in transfer
buffer, allowing time for SDS to diffuse out, thus enhancing protein transfer. The PDVF membrane
was first activated by submersion in 100% methanol for 10 seconds and then equilibrated in Toubin
transfer buffer (Bio-Rad; Hercules, CA) for 15 min. Samples were transferred onto the PVDF
membrane using Bio-Rad Turbo-blot Transfer Machine using the Bio-Rad defined settings specific
for mini gel transfers of standard molecular weight proteins. The membrane was removed and
washed 3 times for 15 min with Tris-buffered saline containing 0.1% Tween-20 (TBS-T). The
membrane was then blocked with 4% milk in TBS-T for 30 min and washed with TBS-T. The
rabbit sera containing the subunit-specific antibodies (New England peptide; Gardner, MA) were
diluted 1:10,000 in TBS-T containing 4% milk and applied to the membrane overnight, rocking at
4°C. The membrane was washed with TBS-T, and an HRP-conjugated IgG goat anti-rabbit
15

secondary antibody (Jackson Immunoresearch; West Grove, PA) diluted 1:20,000 in TBS-T
containing 4% milk was applied to the membrane for 30 min with rocking at room temperature.
The membrane was washed and visualized by chemiluminescence using ECL solution adapted
from [45].

Size exclusion chromatography
1 mg each of CdtB and CdtC were combined for 24 h in 5 mL of 20 mM Tris (pH 7.4) containing
150 mM NaCl, gently rocking at 4°C. This was then concentrated to <500 µL using a Vivaspin™
concentrator (GE Healthcare; Chicago, IL) with a 1 kDa MWCO. The concentrated sample was
separated by size exclusion chromatography (SEC) using Sephadex® G-75 resin (GE Healthcare)
at a flow rate of 1 mL/min, measuring the absorbance at 280 nm. Key fractions were combined
and concentrated after identification by SDS-PAGE and Coomassie stain.

ATP agarose pull-down assay
100 µL of ATP-conjugated agarose beads (Sigma; St. Louis, MO) was added to a 1.7 mL
microcentrifuge tube. Beads were pelleted at 2,000 × g for 3 min and washed twice with 1 mL
PBS to remove any preservatives and broken beads. The remaining beads were blocked with 1 mL
of PBS containing 0.1% bovine serum albumin for 30 min at 37°C and then washed twice with
PBS. 250 ng of a toxin subunit was added to the beads in 1 mL total volume for a 30 min, 37°C
incubation. The beads were pelleted at 2,000 × g for 3 min, the supernatant was collected, and the
beads were washed twice with PBS. 100 µL of sample buffer was added to the beads, which were
then boiled for 10 min. The collected supernatant was lyophilized before resuspension in 100 µL
of sample buffer and boiled. 20 µL of the bead sample and 5 µL of the supernatant sample was
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resolved via SDS-PAGE and visualized by Western blot. Unconjugated or GTP-conjugated
agarose beads (Sigma) were used in an identical manner. For the competition assays, 250 ng of
CdtB was pre-treated with 10 mM ATP or GTP for 30 min at 37°C. An identical procedure was
used for pull-downs with 250 ng of a CdtB/CdtC heterodimer that was previously after isolated by
SEC.

ATPase assay
HrpA and the individual Cdt subunits were used in a modified regenerative ATPase assay, adapted
from [46, 47]. A 20x master mix (20 mM NADH, 150 mM phosphoenolpyruvate, and ~10 U/mL
of pyruvate kinase/lactate dehydrogenase mixture (Sigma)) was combined in 25 mM HEPES-Tris
with 100 mM K+-glutamate, 12 mM magnesium acetate, 0.05% octyl glucose neopentyl glycol,
and 14 mM β-mercaptoethanol (pH 7.6). 2x assay mixes were prepared in assay buffer
supplemented with 200 µM ATP or 200 µM GTP. 30 µL of the assay mix and 30 µL of protein
(final concentration at 100 nM for HrpA or 500 nM for each individual Cdt subunits) were
combined; 50 µL was then transferred into a 96-well plate. The oxidation of NADH was recorded
every minute over 90 min, measuring the absorbance at 340 nm. After subtracting the measurement
of a reaction mixture absent of protein, a slope was generated by taking the linear regression of
accumulated measurements and converted to µM of ATP turnover per mol of enzyme per min
using Prism 8 (GraphPad; San Diego, CA). Blank subtraction and unit conversion was carried out
using Microsoft Excel (Microsoft; Redmond, Wa).
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Cellular viability assay
Wildtype and TZM cells lacking protein disulfide isomerase (PDI) were cultured in Dulbecco's
Modified Eagle Medium (DMEM) supplemented with 5% fetal bovine serum and antibioticantimycotic until reaching 80% confluency in a 10 cm dish [48]. Cells were lifted using 1 mL of
Gibco™ (ThermoScientific) Trypsin-EDTA and diluted 1:20 into a 96-well plate until reaching
80% confluency overnight. Cells were washed twice and then incubated with various combinations
of Cdt subunits overnight at 37°C in serum-free media. Before addition to the cells, the Cdt subunit
combinations were assembled overnight at 4°C with each subunit at concentration of 1 µg/mL.
Cells were then washed twice to remove unbound toxin and incubated in toxin-free, serumcontaining media for another 48 h. As a control for cell death, a set of unintoxicated cells were
incubated with 10% DMSO in DMEM for 20 min. All cells were washed twice before viability
was determined using an MTS assay according to the manufacturer’s protocol (Promega; Madison,
WI).

Circular Dichroism (CD)
CdtB at 1 mg/mL was dialyzed three times against 1 L of 20 mM phosphate buffer (pH 7.4) for 2
h per exchange. Spectral measurements using 150 µg of dialyzed CdtB in 200 µL volume with a
1 mm pathlength quartz cuvette were averaged after 5 scans, using the accumulation feature of the
JASCO (Tokyo, Japan) spectral analysis software. As a reference, a blank spectral measurement
was generated with filter-sterilized phosphate buffer (pH 7.4). The spectrum of the blank was then
subtracted from the spectrum of CdtB alone or CdtB with 500 µM ATP. All spectral scans were
taken using a JASCO J-1100 Circular Dichroism Spectropolarimeter between the 260-200 nm
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region at a scanning speed of 10 nm/min with a data pitch of 0.1 nm and a digital integration time
(D.I.T.) of 4 sec.

19

CHAPTER 4: RESULTS
Isolation of the CdtB/CdtC complex using functionally pure subunits
After initial purification of the available Cdt subunits, there was an unexpected increase in
individual subunit kDa size for each subunit compared to the size of the native subunits without
signal sequences. DNA sequencing revealed there was a 24 amino acid linker present between the
N-terminal hexahistidine tag and protein sequence for each subunit. This was subsequently
removed by ‘Round-the-horn site-directed mutagenesis. After sequences of the re-cloned Cdt
subunits were verified correct and absent of mutation, the individual recombinant subunits were
re-purified. The average yield of purified CdtA, CdtB and CdtC per 1 L of bacterial culture was
4.5, 6, and 6.4 mg, respectively. A representative SDS-PAGE gel of the purified subunits is shown
in Fig. 5A. Polyclonal antibodies were previously generated against the individual subunits
containing the N-terminal extension using a for-fee service (New England Peptide; Gardner, MA).
Those antibodies are specific for their cognate subunit, without cross-reactivity to the other two
native subunits (Fig. 5B).

Functionality of the refolded subunits was verified by MTS assay and SEC. Assembly into a
functional holotoxin with the individual subunits was observed in vivo by measuring cellular
viability using an MTS assay. Various combinations of Cdt subunits were incubated with wildtype
and PDI-deficient TZM cells. Consistent with the known toxicity of CDT, only exposure to CDT
holotoxin resulted in a decrease in cellular viability (Fig. 6) [49]. This demonstrated that each of
the recombinant subunits was refolded correctly and could spontaneously assemble into a

20

functional holotoxin. This also shows that PDI is not required for disassembly for a cytotoxic effect
compared to other AB toxins that contain disulfide linkages [32].

After confirming CdtA, CdtB, and CdtC spontaneously assembled into a functional holotoxin, the
CdtB/CdtC heterodimer was then isolated. CdtB and CdtC were combined overnight, followed by
SEC using Sephadex® G-75 resin to separate the CdtB/CdtC heterodimer from the unassembled
CdtB and CdtC subunits. There were two peaks present in the SEC absorbance (Fig. 7A). Samples
from the collected fractions were resolved by SDS-PAGE and visualized by Coomassie stain (Fig.
7B). Fractions 20-23 were collected due to equal band intensities for CdtB and CdtC that represent
the heterodimer eluting off the column. Fractions 11-19 that make up the first peak were not
collected due to dimers of CdtB and dimers of CdtC present when visualized by Western blot (data
not shown).
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Figure 5: Purification of individual Cdt subunits and antibody specificity.
(A) CdtA, CdtB and CdtC were purified by affinity chromatography using TALON cobalt resin.
After protein refolding, 2 µg of each subunit was resolved using a 15% Tris-glycine SDS-PAGE
gel and visualized by Coomassie stain. (B) The individual subunits at the indicated amounts were
resolved by 15% Tris-glycine SDS-PAGE gel and detected by Western blot with anti-CdtA, antiCdtB, or anti-CdtC polyclonal antibodies.
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Figure 6: Cellular viability measured by MTS after CDT intoxication.
Wildtype and PDI-deficient TZM cells were incubated overnight with various combinations of
Cdt subunits that were allowed to first assemble overnight. Cellular viability was measured by
MTS assay after 72 h from the initial toxin exposure. For a positive control, both cell types were
also incubated with 10% DMSO for 20 min.
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Figure 7: Isolation of CdtB/CdtC heterodimer by SEC.
(A) 1 mg each of CdtB and CdtC were combined, incubated overnight at 4 °C, and separated using
Sephadex G-75 resin at a flow rate of 1 mL/min. Protein elutions were measured by absorbance at
280 nm (A. U.). (B) Fractions 4-28 were collected and visualized by 15% Tris-glycine SDS-PAGE
gel and Coomassie stain. Fractions are labeled to their corresponding lane.
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CdtB binds to ATP but is not an ATPase
After functionality was demonstrated, we investigated if CdtA, CdtB, or CdtC can bind to ATP.
250 ng of CdtA, CdtB, or CdtC were incubated individually with ATP-conjugated or GTPconjugated agarose beads for 30 min at 37°C. The beads were washed to remove unbound subunits,
resuspended in sample buffer, boiled, and then visualized by Western blot. Only CdtB was
detectable in the pellet after incubation (Fig. 8A). These results demonstrated that CdtB is the only
subunit that binds to ATP. CdtB bound to GTP as well, whereas CdtA and CdtC did not (Fig. 8A).
ATP binding was eliminated by pre-treating CdtB with 10 mM of soluble ATP for 30 min before
the addition to the beads (Fig. 8B). Furthermore, CdtB was not detected in association with
unconjugated agarose beads. This verifies that CdtB was binding to ATP.

Since CdtB can bind to ATP, we determined whether this subunit functions as an ATPase. Using
a regenerative GTPase assay modified for ATPase activity, 100 µM ATP along with either 500
nM of CdtA, CdtB, or CdtC were combined and indirectly measured for ATP hydrolysis. After
subtracting the natural decay of ATP, a rate of µM of ATP being regenerated (ADP being
converted back to ATP), per mol of subunit in solution, per min was calculated from the average
of 3 reactions. No subunit exhibited ATPase function (Fig. 9), indicating that ATP hydrolysis does
not induce disassembly. This also shows that CdtA and CdtC were not released from the ATPagarose beads due to ATP hydrolysis, which strengthened our interpretation of the ATP pulldown
assay. The RNA helicase, HrpA, was used a positive control. A similar assay determined that none
of the Cdt subunits exhibited GTPase activity.
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Figure 8: Only CdtB is able to bind ATP and GTP.
(A) 250 ng of CdtA, CdtB, or CdtC were incubated with ATP-conjugated (lane 2) or GTPconjugated (lane 3) agarose beads for 30 min. The beads were then pelleted, washed, and
resuspended in 100 µL of sample buffer. 20 ng of pure individual subunit (lane 1) was used as a
loading control for the Western blot. (B) 250 ng of CdtB was incubated with ATP-conjugated
agarose beads (lane 1) or unconjugated agarose beads (lane 2) for 30 min. 250 ng of CdtB was
pretreated with 10 mM of soluble ATP (lane 3) or 10 mM soluble GTP (lane 4) for 30 minutes,
then incubated with ATP-conjugated agarose beads for 30 min and visualized in the same manner
as (A).
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Figure 9: No Cdt subunit functions as an ATPase.
100 nM HrpA, 500 nM of CdtA, CdtB, or CdtC were measured for ATPase activity using a
regenerative assay containing 100 µM ATP. The graph represents the combined average of 3
reactions with standard deviation included.
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ATP induced the disassembly of CdtB/CdtC but did not alter CdtB’s overall structure
After identifying that only CdtB is binding to ATP, we wanted to verify that CdtC was not blocking
the ATP binding site in the CdtB/CdtC heterodimer. 250 ng of the CdtB/CdtC heterodimer was
incubated for 30 min at 37 °C with ATP-conjugated agarose beads. Both the supernatant and the
beads were probed by Western blot. CdtB was detected in both the pellet and supernatant samples.
Surprisingly, CdtC was only detected in the supernatant (Fig. 10A), indicating (i) CdtC does not
block the ATP-binding site in CdtB and (ii) CdtC dissociated from CdtB bound to ATP-conjugated
agarose beads. The use of GTP-conjugated agarose beads generated similar results as ATPconjugated agarose beads (Fig. 10B). Thus, binding of either ATP or GTP to CdtB will cause the
release of CdtC.

To better understand ATP’s role in the CdtB/CdtC disassembly mechanism, we investigated if
ATP causes a structural change that is inducing dissociation. Using CD, far-UV spectral scans of
CdtB’s overall secondary structure were generated with and without ATP. There is one minima
present around 210 nm with both conditions. This distinct spectral characteristic is associated with
a protein’s secondary structure having a higher percentage of beta sheet structure than alpha helical
structure. This is true for CdtB as verified by the holotoxin crystal structure [7]. After the addition
of ATP, no major changes are distinguished when comparing the two CdtB spectra, indicating that
ATP does not change the overall secondary structure of CdtB (Fig. 11). This suggests that the
disassembly of CdtB/CdtC may be caused by a mechanism other than a structure change in CdtB.
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Figure 10: ATP-induced disassembly of the CdtB/CdtC heterodimer by ATP-conjugated
agarose beads.
250 ng of the CdtB/CdtC heterodimer isolated by SEC was incubated with ATP-conjugated
agarose beads for 30 min. The supernatant was collected and lyophilized, while the beads (pellet)
were washed, and then both were resuspended sample buffer. All samples were resolved by 15%
Tris-glycine SDS-PAGE gel and visualized by Western blot.
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Figure 11: ATP does not alter the overall secondary structure of CdtB.
The far-UV spectra of CdtB at 100 µg/mL with 500 µM ATP (dotted line) or without ATP (solid
line) in 20 mM phosphate buffer (pH 7.4) are presented. One of the experiments is shown, with
each spectrum representing the average of five scans after buffer subtraction.
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CHAPTER 5: DISCUSSION
Here we have presented evidence that ATP plays a critical role in the novel two-stage disassembly
of CDT. Although the CDT holotoxin binds to the cell surface, CdtA dissociates before reaching
the Golgi apparatus [21]. This is the first stage of disassembly. The loss of CdtC, presumably in
the ER, represents the second stage of disassembly [10]. CdtC dissociation for CdtB activity is
required since the DNase I active site is blocked by the N-terminal tail of CdtC [7, 11, 29].

Currently, there are many studies on CDT including the identification of the surface receptor, the
intracellular trafficking route, and the cellular response mechanisms to the DNA damage caused
by CDT [6, 19, 21]. There are currently no studies that detail the molecular basis for disassembly
of CDT. Previously, it has been shown that PT disassembles in the ER after ATP binds to the PTB
pentamer [34-36]. Preliminary results generated from the Teter lab indicated that the addition of
ATP will also cause the disassembly of the CdtB/CdtC heterodimer. After purification of the
functional individual Cdt subunits and isolation of the CdtB/CdtC heterodimer, we demonstrated
that ATP induces CdtB/CdtC disassembly by binding to CdtB. However, ATP binding did not
cause an overall change to the secondary structure of CdtB. Furthermore, CdtB did not hydrolyze
ATP. The use of the GTP generated similar results, demonstrating that this mechanism is not
specific to only ATP. This likely represents a nucleotide-binding site present in CdtB, and further
testing using CTP and TTP is needed to confirm this.

It is currently understood that assembly of the CDT holotoxin is 100% efficient [50, 51]. Since
there are no monomers detected from the SEC profile, this would serve as a confirmation and could
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be validated by performing SEC after assembling the CdtB/CdtC heterodimer with one subunit at
an excess. The use of native-PAGE electrophoresis would confirm that the CdtB/CdtC heterodimer
is isolated, validating the ATP- and GTP-conjugated agarose results. This method could serve as
an alternative to modeling disassembly as well.

Future studies using crystallography with CdtB and ATP are needed to (i) identify the location of
CdtB’s ATP-binding pocket, and (ii) any subtle structural changes not detectable by CD. The
location of the ATP-binding pocket could potentially be in the groove between CdtB and CdtC. In
this scenario, ATP would be functioning as a competitive inhibitor for CdtB that acts as a wedge
separating the two subunits. Alternatively, ATP’s interaction with CdtB could perhaps be
functioning as an allosteric regulator altering the intrachain interactions in CdtB as ATP binds,
inducing CdtC dissociation. Additional experimentation with the CDT holotoxin will address if
CdtA has an inhibitory effect on the ATP-induced disassembly CdtB/CdtC heterodimer. This could
be caused by CdtA blocking the ATP-binding pocket, or as an alternative, CdtA could be
stabilizing the protein-protein interaction between CdtA and CdtC. A mutagenesis study that
introduces point mutations into the active site of the ATP-binding pocket will further identify the
amino acids that are required to induce the disassembly of the CdtB/CdtC heterodimer.

The CD method of measuring changes to secondary structure of CdtB is not without limitation due
to ATP absorbing light in the far UV region [52]. Attempts to increase the ATP concentration
higher than what were described here produced spectra with unacceptable signal to noise ratios.
However, the concentration of ATP might not be high enough to induce a conformational change
to be seen by conventional biophysical approaches. Furthermore, the lack of an overall structural
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change in CdtB with ATP using CD does not rule out possible changes to local structure at the
tested concentration of 200 µM ATP. While the predominant beta sheet structure remained
unchanged, there may be unfolding and refolding of partial alpha helical structures. These changes
could possibly be distinguished by a change in protease sensitivity that was previously used to
demonstrate CdtB’s thermal stability [53]. This would be confirmed by crystallography with CdtB
and ATP.

We have shown here that CDT is the second AB toxin that appears to use an ATP-induced
disassembly mechanism as a part of its overall two-stage disassembly process. This mechanism
may act as a molecular sensor upon ATP binding to CdtB that causes the disassembly of the
CdtB/CdtC heterodimer that is triggered by the initial interaction of ATP after toxin delivery to
the ER.

33

LIST OF REFERENCES

1.

Fais, T., et al., Impact of CDT Toxin on Human Diseases. Toxins (Basel), 2016. 8(7).

2.

Steen, R., Eradicating chancroid. Bull World Health Organ, 2001. 79(9): p. 818-26.

3.
Marks, M., et al., Challenges and key research questions for yaws eradication. Lancet
Infect Dis, 2015. 15(10): p. 1220-1225.
4.
Gonzalez-Beiras, C., et al., Epidemiology of Haemophilus ducreyi Infections. Emerg Infect
Dis, 2016. 22(1): p. 1-8.
5.
Wising, C., et al., Induction of apoptosis/necrosis in various human cell lineages by
Haemophilus ducreyi cytolethal distending toxin. Toxicon, 2005. 45(6): p. 767-76.
6.
Jinadasa, R.N., et al., Cytolethal distending toxin: a conserved bacterial genotoxin that
blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages.
Microbiology, 2011. 157(Pt 7): p. 1851-75.
7.
Nesic, D., Y. Hsu, and C.E. Stebbins, Assembly and function of a bacterial genotoxin.
Nature, 2004. 429(6990): p. 429-33.
8.
Berman, H.M., et al., The Protein Data Bank and the challenge of structural genomics. Nat
Struct Biol, 2000. 7 Suppl: p. 957-9.
9.
Boesze-Battaglia, K., et al., Cytolethal distending toxin-induced cell cycle arrest of
lymphocytes is dependent upon recognition and binding to cholesterol. J Biol Chem, 2009.
284(16): p. 10650-8.
10.
Guerra, L., et al., Cellular internalization of cytolethal distending toxin: a new end to a
known pathway. Cell Microbiol, 2005. 7(7): p. 921-34.
11.
Nesic, D. and C.E. Stebbins, Mechanisms of assembly and cellular interactions for the
bacterial genotoxin CDT. PLoS Pathog, 2005. 1(3): p. e28.
12.
Eshraghi, A., et al., Cytolethal distending toxin family members are differentially affected
by alterations in host glycans and membrane cholesterol. J Biol Chem, 2010. 285(24): p. 18199207.
13.
Fahrer, J., et al., Cytolethal distending toxin (CDT) is a radiomimetic agent and induces
persistent levels of DNA double-strand breaks in human fibroblasts. DNA Repair (Amst), 2014.
18: p. 31-43.
34

14.
Frisan, T., et al., The Haemophilus ducreyi cytolethal distending toxin induces DNA
double-strand breaks and promotes ATM-dependent activation of RhoA. Cell Microbiol, 2003.
5(10): p. 695-707.
15.
Li, L., et al., The Haemophilus ducreyi cytolethal distending toxin activates sensors of DNA
damage and repair complexes in proliferating and non-proliferating cells. Cell Microbiol, 2002.
4(2): p. 87-99.
16.
Svensson, L.A., P. Henning, and T. Lagergard, The cytolethal distending toxin of
Haemophilus ducreyi inhibits endothelial cell proliferation. Infect Immun, 2002. 70(5): p. 26659.
17.
Boesze-Battaglia, K., et al., A journey of cytolethal distending toxins through cell
membranes. Front Cell Infect Microbiol, 2016. 6(81).
18.
Hontz, J.S., et al., Differences in crystal and solution structures of the cytolethal distending
toxin B subunit: Relevance to nuclear translocation and functional activation. J Biol Chem, 2006.
281(35): p. 25365-72.
19.
Gargi, A., et al., Cellular interactions of the cytolethal distending toxins from Escherichia
coli and Haemophilus ducreyi. J Biol Chem, 2013. 288(11): p. 7492-505.
20.
Frisan, T., Bacterial genotoxins: The long journey to the nucleus of mammalian cells.
Biochim Biophys Acta, 2016. 1858(3): p. 567-75.
21.
Cortes-Bratti, X., et al., Cellular internalization of cytolethal distending toxin from
Haemophilus ducreyi. Infect Immun, 2000. 68(12): p. 6903-11.
22.
Dixon, S.D., et al., Distinct Roles for CdtA and CdtC during Intoxication by Cytolethal
Distending Toxins. PLoS One, 2015. 10(11): p. e0143977.
23.
Deng, K. and E.J. Hansen, A CdtA-CdtC complex can block killing of HeLa cells by
Haemophilus ducreyi cytolethal distending toxin. Infect Immun, 2003. 71(11): p. 6633-40.
24.
Damek-Poprawa, M., et al., Localization of Aggregatibacter actinomycetemcomitans
Cytolethal Distending Toxin Subunits during Intoxication of Live Cells. Infect Immun, 2012. 80(8):
p. 2761-70.
25.
Frisan, T., 20 - Bacterial genotoxins, in The Comprehensive Sourcebook of Bacterial
Protein Toxins (Fourth Edition), J. Alouf, D. Ladant, and M.R. Popoff, Editors. 2015, Academic
Press: Boston. p. 558-602.
26.
Baeuerle, P.A. and W.B. Huttner, Tyrosine sulfation is a trans-Golgi-specific protein
modification. J Cell Biol, 1987. 105(6 Pt 1): p. 2655-64.
27.
Breitling, J. and M. Aebi, N-linked protein glycosylation in the endoplasmic reticulum.
Cold Spring Harb Perspect Biol, 2013. 5(8): p. a013359.
35

28.
Guerra, L., et al., The biology of the cytolethal distending toxins. Toxins (Basel), 2011.
3(3): p. 172-90.
29.
Hu, X., D. Nesic, and C.E. Stebbins, Comparative structure-function analysis of cytolethal
distending toxins. Proteins, 2006. 62(2): p. 421-34.
30.
Sixma, T.K., et al., Crystal structure of a cholera toxin-related heat-labile enterotoxin from
E. coli. Nature, 1991. 351(6325): p. 371-7.
31.
Zhang, R.G., et al., The three-dimensional crystal structure of cholera toxin. J Mol Biol,
1995. 251(4): p. 563-73.
32.
Taylor, M., et al., Protein-disulfide isomerase displaces the cholera toxin A1 subunit from
the holotoxin without unfolding the A1 subunit. J Biol Chem, 2011. 286(25): p. 22090-100.
33.

Stein, P.E., et al., The crystal structure of pertussis toxin. Structure, 1994. 2(1): p. 45-57.

34.
Plaut, R.D., et al., Intracellular disassembly and activity of pertussis toxin require
interaction with ATP. Pathog Dis, 2016. 74(6).
35.
Hazes, B., et al., Crystal structure of the pertussis toxin-ATP complex: a molecular sensor.
J Mol Biol, 1996. 258(4): p. 661-71.
36.
Hausman, S.Z., C.R. Manclark, and D.L. Burns, Binding of ATP by pertussis toxin and
isolated toxin subunits. Biochemistry, 1990. 29(26): p. 6128-31.
37.
Clairmont, C.A., A. De Maio, and C.B. Hirschberg, Translocation of ATP into the lumen
of rough endoplasmic reticulum-derived vesicles and its binding to luminal proteins including BiP
(GRP 78) and GRP 94. J Biol Chem, 1992. 267(6): p. 3983-90.
38.
Maxfield, F.R. and D.J. Yamashiro, Endosome acidification and the pathways of receptormediated endocytosis. Adv Exp Med Biol, 1987. 225: p. 189-98.
39.
Medaglia, M.V. and R.J. Fisher, Analysis of Interacting Proteins with Surface Plasmon
Resonance Using Biacore, in Protein-Protein Interactions, E. Golemis, Editor. 2002, Cold Spring
Harbor Laboratory Press: Cold Spring Harbor, New York. p. 255-272.
40.
Homola, J., Present and future of surface plasmon resonance biosensors. Anal Bioanal
Chem, 2003. 377(3): p. 528-39.
41.
Svensson, L.A., et al., The impact of Haemophilus ducreyi cytolethal distending toxin on
cells involved in immune response. Microb Pathog, 2001. 30(3): p. 157-66.
42.
Xu, T., et al., Interactions of Haemophilus ducreyi and purified cytolethal distending toxin
with human monocyte-derived dendritic cells, macrophages and CD4+ T cells. Microbes Infect,
2004. 6(13): p. 1171-81.

36

43.
Bertani, G., Lysogeny at mid-twentieth century: P1, P2, and other experimental systems. J
Bacteriol, 2004. 186(3): p. 595-600.
44.
OpenWetWare. 'Round-the-horn site-directed mutagenesis. 10 December 2018 22:18 UTC
[cited
2019
June
2];
Available
from:
https://openwetware.org/mediawiki/index.php?title=%27Round-the-horn_sitedirected_mutagenesis&oldid=1055958.
45.
Chung, C.T., S.L. Niemela, and R.H. Miller, One-step preparation of competent
Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc Natl
Acad Sci U S A, 1989. 86(7): p. 2172-5.
46.
Ingerman, E. and J. Nunnari, A continuous, regenerative coupled GTPase assay for
dynamin-related proteins. Methods Enzymol, 2005. 404: p. 611-9.
47.
Wingo, R.J., et al., Exacerbation of [delta]efp sickness in Escherichia coli by an
uncharacterized RNA helicase. p. 1 online resource (xiv, 82 pages).
48.
Ou, W. and J. Silver, Role of protein disulfide isomerase and other thiol-reactive proteins
in HIV-1 envelope protein-mediated fusion. Virology, 2006. 350(2): p. 406-17.
49.
Lara-Tejero, M. and J.E. Galan, CdtA, CdtB, and CdtC form a tripartite complex that is
required for cytolethal distending toxin activity. Infect Immun, 2001. 69(7): p. 4358-65.
50.
Cao, L., et al., Characterization of point mutations in the cdtA gene of the cytolethal
distending toxin of Actinobacillus actinomycetemcomitans. Mol Microbiol, 2005. 58(5): p. 130321.
51.
Cao, L., et al., Role of aromatic amino acids in receptor binding activity and subunit
assembly of the cytolethal distending toxin of Aggregatibacter actinomycetemcomitans. Infect
Immun, 2008. 76(7): p. 2812-21.
52.
Ito, A. and T. Ito, Absorption spectra of deoxyribose, ribosephosphate, ATP and DNA by
direct transmission measurements in the vacuum-UV (150-190 nm) and far-UV (190-260 nm)
regions using synchrotron radiation as a light source. Photochem Photobiol, 1986. 44(3): p. 3558.
53.
Guerra, L., et al., A novel mode of translocation for cytolethal distending toxin. Biochim
Biophys Acta, 2009. 1793(3): p. 489-95.

37

